JCRファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/02/21 | 5,280 | 5,420 | 5,260 | 5,360 | +30 | +0.6% | 99,300 |
2018/02/20 | 5,300 | 5,350 | 5,230 | 5,330 | -10 | -0.2% | 85,700 |
2018/02/19 | 5,350 | 5,400 | 5,280 | 5,340 | +50 | +0.9% | 84,600 |
2018/02/16 | 5,240 | 5,380 | 5,200 | 5,290 | +110 | +2.1% | 131,000 |
2018/02/15 | 5,200 | 5,310 | 5,140 | 5,180 | -20 | -0.4% | 119,100 |
2018/02/14 | 5,180 | 5,280 | 5,100 | 5,200 | +20 | +0.4% | 155,200 |
2018/02/13 | 5,270 | 5,370 | 5,180 | 5,180 | -50 | -1% | 157,200 |
2018/02/09 | 5,130 | 5,250 | 5,050 | 5,230 | -140 | -2.6% | 173,700 |
2018/02/08 | 5,180 | 5,420 | 5,180 | 5,370 | +220 | +4.3% | 159,200 |
2018/02/07 | 5,300 | 5,460 | 5,140 | 5,150 | +150 | +3% | 181,500 |
2018/02/06 | 5,060 | 5,160 | 4,815 | 5,000 | -460 | -8.4% | 308,300 |
2018/02/05 | 5,480 | 5,570 | 5,430 | 5,460 | -130 | -2.3% | 148,700 |
2018/02/02 | 5,620 | 5,630 | 5,510 | 5,590 | -90 | -1.6% | 126,100 |
2018/02/01 | 5,500 | 5,720 | 5,460 | 5,680 | +180 | +3.3% | 157,400 |
2018/01/31 | 5,380 | 5,650 | 5,380 | 5,500 | +140 | +2.6% | 214,800 |
2018/01/30 | 5,200 | 5,530 | 5,200 | 5,360 | +150 | +2.9% | 303,600 |
2018/01/29 | 5,590 | 5,610 | 5,190 | 5,210 | -400 | -7.1% | 385,500 |
2018/01/26 | 5,930 | 5,950 | 5,560 | 5,610 | +80 | +1.4% | 461,800 |
2018/01/25 | 6,000 | 6,040 | 5,480 | 5,530 | -410 | -6.9% | 376,200 |
2018/01/24 | 5,790 | 5,990 | 5,730 | 5,940 | +230 | +4% | 166,500 |
2018/01/23 | 5,630 | 5,760 | 5,610 | 5,710 | +170 | +3.1% | 157,100 |
2018/01/22 | 5,680 | 5,710 | 5,520 | 5,540 | -220 | -3.8% | 241,800 |
2018/01/19 | 5,760 | 5,830 | 5,660 | 5,760 | ±0 | ±0% | 116,700 |
2018/01/18 | 6,000 | 6,090 | 5,740 | 5,760 | -70 | -1.2% | 203,500 |
2018/01/17 | 5,800 | 5,880 | 5,740 | 5,830 | -10 | -0.2% | 85,600 |
2018/01/16 | 6,000 | 6,040 | 5,810 | 5,840 | -120 | -2% | 164,800 |
2018/01/15 | 5,760 | 5,960 | 5,680 | 5,960 | +270 | +4.7% | 117,900 |
2018/01/12 | 5,620 | 5,820 | 5,590 | 5,690 | +40 | +0.7% | 144,900 |
2018/01/11 | 5,760 | 5,850 | 5,560 | 5,650 | -90 | -1.6% | 147,200 |
2018/01/10 | 5,600 | 5,770 | 5,580 | 5,740 | +160 | +2.9% | 124,100 |
2018/01/09 | 5,500 | 5,620 | 5,460 | 5,580 | +120 | +2.2% | 108,300 |
2018/01/05 | 5,400 | 5,480 | 5,310 | 5,460 | +110 | +2.1% | 76,400 |
2018/01/04 | 5,250 | 5,380 | 5,240 | 5,350 | +40 | +0.8% | 117,700 |
2017/12/29 | 5,370 | 5,400 | 5,270 | 5,310 | -40 | -0.7% | 59,300 |
2017/12/28 | 5,400 | 5,410 | 5,320 | 5,350 | -50 | -0.9% | 73,000 |
2017/12/27 | 5,290 | 5,430 | 5,260 | 5,400 | +100 | +1.9% | 99,500 |
2017/12/26 | 5,200 | 5,360 | 5,190 | 5,300 | +100 | +1.9% | 133,100 |
2017/12/25 | 5,180 | 5,250 | 5,130 | 5,200 | +70 | +1.4% | 74,800 |
2017/12/22 | 5,060 | 5,190 | 5,050 | 5,130 | -10 | -0.2% | 141,600 |
2017/12/21 | 5,250 | 5,360 | 5,110 | 5,140 | -80 | -1.5% | 222,800 |
2017/12/20 | 5,100 | 5,320 | 5,060 | 5,220 | +190 | +3.8% | 192,000 |
2017/12/19 | 5,000 | 5,050 | 4,955 | 5,030 | +65 | +1.3% | 71,900 |
2017/12/18 | 5,080 | 5,080 | 4,885 | 4,965 | -35 | -0.7% | 127,300 |
2017/12/15 | 4,990 | 5,010 | 4,855 | 5,000 | -10 | -0.2% | 149,400 |
2017/12/14 | 4,865 | 5,120 | 4,845 | 5,010 | +210 | +4.4% | 268,500 |
2017/12/13 | 4,810 | 4,870 | 4,775 | 4,800 | -40 | -0.8% | 61,900 |
2017/12/12 | 4,835 | 4,875 | 4,785 | 4,840 | +5 | +0.1% | 65,500 |
2017/12/11 | 4,810 | 4,845 | 4,755 | 4,835 | +85 | +1.8% | 82,900 |
2017/12/08 | 4,745 | 4,780 | 4,665 | 4,750 | ±0 | ±0% | 96,500 |
2017/12/07 | 4,695 | 4,770 | 4,695 | 4,750 | +80 | +1.7% | 64,800 |
1651~
1700
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「JCRファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
JCRファーマ | 74,800円 | -3.7% | -36.7% | 2.67% | 24.63倍 | 1.61倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
ネクセラファーマ | 114,200円 | +197.7% | - | 0.00% | 46.67倍 | 1.49倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 150,400円 | +3.2% | +4.5% | 3.46% | 17.28倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 210,200円 | +0.4% | -8.4% | 2.52% | 27.78倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
サンバイオ | 96,800円 | - | - | 0.00% | - | 48.74倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム